INOVIO (NASDAQ:INO) today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA® 3PSP smart device and the procurement of CELLECTRA® 2000 devices, which are used to deliver INO-4800 directly into the skin.
Phase1 results will be in july/august.
Why not wait til Phase1 results before you throw $71mm their way?
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links